Early research (Phase 1)Ended earlyNCT04691375What this trial is testingPY314 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorGynecologic CancerBreast Cancer+6 more Ikena Oncology 86
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Post-approval studies (Phase 4)Study completedNCT00706706What this trial is testingSafety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Pfizer 105
Early research (Phase 1)Study completedNCT00005816What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV Kidney CancerWho this might be right forKidney Cancer Duke University 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680What this trial is testingDiet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT04903873What this trial is testingEvaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsWho this might be right forSolid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more Eutilex 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163What this trial is testingPh I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid TumorsWho this might be right forSolid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more Vyriad, Inc. 33
Not applicableEnded earlyNCT03709771What this trial is testingNovel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular DiseaseWho this might be right forRenal Cell CarcinomaHypertensionMelanoma+1 more Vanderbilt University Medical Center 2
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Not applicableStudy completedNCT02527304What this trial is testingAdaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by SurgeryWho this might be right forMelanomaMetastatic Malignant Neoplasm in the SpineRenal Cell Carcinoma+2 more Albert Einstein College of Medicine 24
Early research (Phase 1)Ended earlyNCT00747305What this trial is testingSunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By SurgeryWho this might be right forKidney Cancer Harry Drabkin 17
Testing effectiveness (Phase 2)Ended earlyNCT00467077What this trial is testingGefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer California Cancer Consortium 21
Testing effectiveness (Phase 2)UnknownNCT02072031What this trial is testingPhase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）Who this might be right forAnlotinibRCC Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 133
Early research (Phase 1)Study completedNCT01714765What this trial is testingDose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal CancerWho this might be right forMetastatic Clear Cell Renal Cancer Queen Mary University of London 17
Not applicableActive Not RecruitingNCT07332923What this trial is testingPredicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine LearningWho this might be right forRenal Clear Cell CarcinomaHIF-2αRadiomics+1 more First Affiliated Hospital of Fujian Medical University 500
Testing effectiveness (Phase 2)UnknownNCT02787915What this trial is testingDC1s-CTL Cellular Therapy for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Xuzhou Medical University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487What this trial is testingNDI 1150-101 in Patients With Solid TumorsWho this might be right forSolid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Ended earlyNCT00485563What this trial is testingA Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Endocyte 12
Not applicableStudy completedNCT01404104What this trial is testingNeo-adjuvant Temsirolimus in Patients With Advanced Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma St. Joseph's Healthcare Hamilton 11
Testing effectiveness (Phase 2)Study completedNCT01566747What this trial is testingSecond-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5Who this might be right forRenal Cell Carcinoma Cancer Trials Ireland 43